Ron Bentsur - Mar 18, 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Mar 18, 2024
Transactions value $
$51,450
Form type
4
Date filed
3/19/2024, 08:00 AM
Previous filing
Oct 12, 2023
Next filing
Mar 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $51.5K +5K +0.15% $10.29 3.24M Mar 18, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.